Diagnostics Industry

Found 2,045 articles

• U.S. Ski & Snowboard and Orig3n in Multi-Year Partnership

  1/16/2019

  U.S. Ski & Snowboard and Orig3n, Inc. are excited to announce Orig3n as the Official Genetics Partner of the U.S. Ski & Snowboard Team.

• 

  Top 10 Cities in the U.S. for the Job Market

  1/15/2019

  New Year, fresh start? Could be. WalletHub recently compared more than 180 cities across the U.S., using 30 key indicators to evaluate their job strength. Some of those factors were job opportunities, employment growth, monthly average starting salary and employment outlook.
• 

  Your Feedback Matters! Topics in 2019

  1/15/2019

  As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2019. Let us know which topics you want to hear more about.

• Nurx Launches Home HPV Screening Test

  1/15/2019

  The telemedicine company introduces convenient and affordable lab testing for women to check their risk for cervical cancer

• BrainScope Announces Publication Describing Proprietary Concussion Biomarker to Assess Potential Severity and Predict Prolonged Recovery

  1/15/2019

  Future Capability Could Aid in Objective Return-to-Activity Decisions

• MDxHealth (R): MDxHealth Provides Business Update January 14, 2019

  1/14/2019

  MDxHealth SA today issued a preliminary update on its 2018 financial results.

• NRGene and TOYOTA Collaborate to Develop Strawberry Varieties to Better Enable Local Production for the Japanese Market

  1/13/2019

  NRGene and Toyota announced today the decoding of a leading commercial strawberry genome, a key milestone in the development of high-quality, locally-produced fruits for the Japanese market.

• NRGene and Macrogen Launch Ultra-High-Density SNP Genotyping Service

  1/12/2019

  ArrayMAGIC is designed to provide convenient, cost-effective, and high-resolution genotyping

• Abbott and "Malaria No More" Work Together to End Malaria in Odisha, India

  1/11/2019

  Abbott to supply rapid diagnostic tests critical for malaria detection and surveillance, technical expertise and funding support

• Former Olympian & Professional Athlete Howard Dell Joins Neurologics Board Of Advisors To Guide Peak Performance Opportunities

  1/10/2019

  Neurologics has announced the appointment of Howard Dell to its Board of Advisors.

• Co-Diagnostics, Inc. to Present at PAG XXVII on January 14 in San Diego

  1/10/2019

  Company Senior Research Scientist will be a guest speaker of LGC, Biosearch

• Positive Assessment Issued for Agendia's MammaPrint®

  1/9/2019

  Determination finds that Agendia's MammaPrint® Breast Cancer Risk of Recurrence test improves net health outcome for patients and positions the test well for further adoption by health insurance plans in the U.S.

• Veracyte to Present at the 21st Annual Needham Growth Conference

  1/9/2019

  Veracyte, Inc. today announced that Bonnie H. Anderson, chairman and chief executive officer, is scheduled to present at the 21st Annual Needham Growth Conference in New York City on Tuesday, January 15, 2019 at 8:40 a.m. EST (5:40 a.m. PST).

• MGI Announces Price and Early Access Customer of MGISEQ-T7

  1/9/2019

  Highest Throughput Sequencer Brings Power of Choice to the Market

• Asuragen Announces Launch of AmplideX® PCR/CE HTT Kit

  1/9/2019

  Asuragen, Inc., a molecular diagnostics company delivering easy-to-use products for complex testing in genetics and oncology, today announced the launch of the AmplideX® PCR/CE HTT Kit*.

• San Diego Blood Chip Maker BioFluidica Awarded Two NIH/NCI Grants for Isolation of Cell-Free DNA and Exosomes on Its Single Liquid Biopsy Platform

  1/8/2019

  BioFluidican has been awarded two separate SBIR Phase I NIH grants, the first in support of "Parallel and high throughput isolation of cancer cell derived extracellular vesicles," and the second in support of "Parallel and high throughput isolation of cfDNA to target detection of rare, highly conserved nucleotide polymorphisms." 

• Sure Med Compliance Partners with Synergy Laboratories to Advance the Fight Against Opioid Abuse

  1/8/2019

  Results from Synergy Laboratories’ Diagnostic Tests to be Integrated into SureMed Compliance’s Reporting and Screening Tools

• Sysmex Canada Names Ian Heynen General Manager of Sysmex Canada

  1/8/2019

  Sysmex Canada, Inc. announced today that Ian Heynen has been named general manager of Sysmex Canada, Inc., a wholly owned subsidiary of Sysmex America.

• Lark Health and 23andMe Collaborate to Integrate Genetic Information in Two New Health Programs

  1/8/2019

  Lark's clinically validated AI coaching programs provide new ways for 23andMe customers to take action on their genetic information

• In Promise of True Liquid Biopsy for Cancer, Chip Company BioFluidica® Awarded $1.7 Million by National Cancer Institute/National Institutes of Health for Clinical Trial in Children with Acute Lymphoblastic Leukemia

  1/8/2019

  BioFluidica has been awarded an SBIR Phase II National Institutes of Health grant of $1.7 million for a clinical trial in support of "Increased sensitivity of minimal residual disease monitoring using peripheral blood in pediatric patients with acute lymphoblastic leukemia."